Narrative updates are currently in beta.

Back to narrative

Update shared on04 Aug 2025

Fair value Increased 9.21%
AnalystConsensusTarget's Fair Value
US$201.64
0.04% undervalued intrinsic discount
07 Aug
US$201.57
Loading
1Y
35.3%
7D
2.7%

Recent modest improvements in SPX Technologies' net profit margin and revenue growth forecasts underpin the upward revision of its consensus analyst price target from $184.64 to $201.64.


What's in the News


  • The company raised its 2025 financial guidance, now expecting revenue of $2.225–$2.275 billion, representing approximately 13% year-on-year growth at the midpoint.
  • No shares were repurchased under the current buyback program between March 30, 2025 and June 28, 2025; cumulative repurchases remain at zero.

Valuation Changes


Summary of Valuation Changes for SPX Technologies

  • The Consensus Analyst Price Target has risen from $184.64 to $201.64.
  • The Net Profit Margin for SPX Technologies has risen slightly from 14.05% to 14.65%.
  • The Consensus Revenue Growth forecasts for SPX Technologies has risen slightly from 8.5% per annum to 8.9% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.